Synthetic and immunological studies of sTn derivatives carrying substituted phenylacetylsialic acids as cancer vaccine candidate

ACS Medicinal Chemistry Letters

Volumn 2, Issue 5, 2011, Pages 373-378

  Wang, Qianli ^a   Guo, Zhongwu ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Cancer vaccine; glycoconjugate; immunology; sTn antigen; sTn derivative; tumor associated carbohydrate antigen

Indexed keywords

5' N 4 ACETYLPHENYLACETYL STN; 5' N 4 CHLOROPHENYLACETYL STN; 5' N 4 METHOXYLPHENYLACETYL STN; 5' N 4 METHYLPHENYLACETYL STN; CANCER VACCINE; CARBOHYDRATE ANTIGEN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; N PHENYLACETYL STN; SIALIC ACID DERIVATIVE; TUMOR ASSOCIATED CARBOHYDRATE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CANCER CELL; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOGENICITY; METABOLIC ENGINEERING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

MUS;

EID: 79956142362     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml100313d     Document Type: Article

References (29)

1. Troy, F. A., 2nd Polysialylation: From bacteria to brains Glycobiology 1992, 2, 5-23
2. Fukuda, M. Possible roles of tumor-associated carbohydrate antigens Cancer Res. 1996, 56, 2237-44 (Pubitemid 26154066)
3. Scheidegger, E. P.; Lackie, P. M.; Papay, J.; Roth, J. In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule Lab. Invest. 1994, 70, 95-106 (Pubitemid 24080109)
4. Hakomori, S.; Zhang, Y. Glycosphingolipid antigens and cancer therapy Chem. Biol. 1997, 4, 97-104 (Pubitemid 27161748)
5. Helling, F.; Shang, A.; Calves, M.; Zhang, S.; Ren, S.; Yu, R. K.; Oettgen, H. F.; Livingston, P. O. GD3 vaccines for melanoma: Superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines Cancer Res. 1994, 54, 197-203
6. Danishefsky, S. J.; Allen, J. R. From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix Angew. Chem., Int. Ed. Engl. 2000, 39, 836-863 (Pubitemid 30217267)
7. Yonezawa, S.; Tachikawa, T.; Shin, S.; Sato, E. Sialosyl-Tn antigen. Its distribution in normal human tissues and expression in adenocarcinomas Am. J. Clin. Pathol. 1992, 98, 167-174
8. Leivonen, M.; Nordling, S.; Lundin, J.; von Boguslawski, K.; Haglund, C. STn and prognosis in breast cancer Oncology 2001, 61, 299-305 (Pubitemid 33135839)
9. Itzkowitz, S. H.; Bloom, E. J.; Kokal, W. A.; Modin, G.; Hakomori, S.; Kim, Y. S. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients Cancer 1990, 66, 1960-1966 (Pubitemid 20385969)
10. Kobayashi, H.; Terao, T.; Kawashima, Y. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer J. Clin. Oncol. 1992, 10, 95-101
11. Kim, G. E.; Bae, H. I.; Park, H. U.; Kuan, S. F.; Crawley, S. C.; Ho, J. J.; Kim, Y. S. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas Gastroenterology 2002, 123, 1052-1060
12. Victorzon, M.; Nordling, S.; Nilsson, O.; Roberts, P. J.; Haglund, C. Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer Int. J. Cancer 1996, 65, 295-300 (Pubitemid 26059983)
13. Kjeldsen, T.; Clausen, H.; Hirohashi, S.; Ogawa, T.; Iijima, H.; Hakomori, S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope Cancer Res. 1988, 48, 2214-2220
14. Itzkowitz, S. H.; Yuan, M.; Montgomery, C. K.; Kjeldsen, T.; Takahashi, H. K.; Bigbee, W. L.; Kim, Y. S. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer Cancer Res. 1989, 49, 197-204 (Pubitemid 19024432)
15. Werther, J. L.; Tatematsu, M.; Klein, R.; Kurihara, M.; Kumagai, K.; Llorens, P.; Guidugli Neto, J.; Bodian, C.; Pertsemlidis, D.; Yamachika, T.; Kitou, T.; Itzkowitz, S. Sialosyl-Tn antigen as a marker of gastric cancer progression: an international study Int. J. Cancer 1996, 69, 193-199 (Pubitemid 26233298)
16. Nakagoe, T.; Sawai, T.; Tsuji, T.; Jibiki, M. A.; Nanashima, A.; Yamaguchi, H.; Yasutake, T.; Ayabe, H.; Arisawa, K.; Ishikawa, H. Predictive factors for preoperative serum levels of sialy Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients Anticancer Res. 2002, 22, 451-458 (Pubitemid 34475338)
17. Holmberg, L. A.; Sandmaier, B. M. Vaccination with Theratope (STn-KLH) as treatment for breast cancer Expert Rev. Vaccines 2004, 3, 655-663 (Pubitemid 39576752)
18. Bresalier, R. S.; Niv, Y.; Byrd, J. C.; Duh, Q. Y.; Toribara, N. W.; Rockwell, R. W.; Dahiya, R.; Kim, Y. S. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis J. Clin. Invest. 1991, 87, 1037-1045
19. Kuberan, B.; Lindhardt, R. J. Carbohydrate based vaccines Curr. Org. Chem. 2000, 4, 653-677 (Pubitemid 30339148)
20. Holmberg, L. A.; Oparin, D. V.; Gooley, T.; Lilleby, K.; Bensinger, W.; Reddish, M. A.; MacLean, G. D.; Longenecker, B. M.; Sandmaier, B. M. Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine Bone Marrow Transplant. 2000, 25, 1233-1241 (Pubitemid 30428137)
21. Liu, T.; Guo, Z.; Yang, Q.; Sad, S.; Jennings, H. J. Biochemical engineering of surface alpha 2-8 polysialic acid for immunotargeting tumor cells J. Biol. Chem. 2000, 275, 32832-32836
22. Pan, Y.; Chefalo, P.; Nagy, N.; Harding, C.; Guo, Z. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines J. Med. Chem. 2005, 48, 875-883 (Pubitemid 40209110)
23. Wu, J.; Guo, Z. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines Bioconjugate Chem. 2006, 17, 1537-1544 (Pubitemid 44851500)
24. Wang, Q.; Ekanayaka, S. A.; Wu, J.; Zhang, J.; Guo, Z. Synthetic and Immunological Studies of 5′- N -Phenylacetyl sTn to Develop Carbohydrate-Based Cancer Vaccines and to Explore the Impacts of Linkage between Carbohydrate Antigens and Carrier Proteins Bioconjugate Chem. 2008, 19, 2060-2067
25. Chefalo, P.; Pan, Y.; Nagy, N.; Guo, Z.; Harding, C. V. Efficient metabolic engineering of GM3 on tumor cells by N -phenylacetyl- d -mannosamine Biochemistry 2006, 45, 3733-3739
26. Meo, C. D.; Demchenko, A. V.; Boons, G. J. A stereoselective approach for the synthesis of alpha-sialosides J. Org. Chem. 2001, 66, 5490-5497
27. Xue, J.; Pan, Y. B.; Guo, Z. W. Neoglycoprotein cancer vaccines: Synthesis of an azido derivative of GM3 and its efficient coupling to proteins through a new linker Tetrahedron Lett. 2002, 43, 1599-1602 (Pubitemid 34169655)
28. Svennerholm, L. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method Biochim. Biophys. Acta 1957, 24, 604-611
29. Casadevall, A.; Pirofski, L. A. Antibody-mediated regulation of cellular immunity and the inflammatory response Trends Immunol. 2003, 24, 474-478 (Pubitemid 37088149)